Avalo Therapeutics (AVTX) Interest Coverage Ratio (2014 - 2015)

Avalo Therapeutics (AVTX) has 13 years of Interest Coverage Ratio data on file, last reported at 0.88 in Q1 2026.

• Quarterly Interest Coverage Ratio rose 99.64% year-over-year to 0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.33 (up 98.46% YoY) and the FY2025 annual result came in at 1.83, down 75.15% from the prior year.
• Interest Coverage Ratio improved to 0.88 in Q1 2026, from 2193.56 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 6.84 in Q3 2022 to a low of 2193.56 in Q4 2025.
• A 5-year average of 245.04 and a median of 13.12 in 2022 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 248.12% — and 2024, when it slumped 18358.37%.
• Tracing AVTX's Interest Coverage Ratio over 5 years: stood at 13.12 in 2022, then jumped by 134.36% to 4.51 in 2023, then plunged by 5021.95% to 221.85 in 2024, then tumbled by 888.76% to 2193.56 in 2025, then jumped by 99.96% to 0.88 in 2026.
• The last three Interest Coverage Ratio figures came in at 0.88 (Q1 2026), 2193.56 (Q4 2025), and 325.39 (Q3 2025), per Business Quant data.